Abstract:
The present invention is directed to novel polypeptides, nucleic acids and related molecules which have an effect on or are related to the cell cycle. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are methods for identifying novel compositions which mediate cell cycle bioactivity, and the use of such compositions in diagnosis and treatment of disease.
Abstract:
The present invention is directed to polypeptides, nucleic acids and related molecules which have an effect on or are related to the cell cycle. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are methods for identifying novel compositions which mediate cell cycle bioactivity, and the use of such compositions in diagnosis and treatment of disease.
Abstract:
The present invention provides compositions and methods for modulating leukocyte activation. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating leukocyte activation are provided. Compositions and methods for the treatment of disorders related to leukocyte dysfunction or dysregulation are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating leukocyte activation.
Abstract:
A mounting plate is disclosed that is adapted to be positioned between a main flow line and at least two differential pressure transmitters, to place the two differential pressure transmitters in fluid communication with a pair of pipeline taps on opposite sides of a flow reducing orifice plate in the main flow line is disclose. The mounting plate includes a plate-like body generally rectangular in cross section along its longitudinal axis and longer than it is wide along its transverse axis. The plate-like body includes a pair of ports that extend through the body and are in fluid communication with the pair of pressure taps with the longitudinal axis of the body parallel to the main flow line. A plurality of passageways or bores extend into the body to connect the ports to various combinations of pressure transmitters. One or more mounting holes for the transmitters are on a line that intersects the longitudinal axis of the body at an angle to allow some of the passageways or bores to be drilled straight and parallel to the longitudinal axis of the body between the mounting holes. In another embodiment, a sub plate is used to supply pressure to a third pressure transmitter. In another embodiment, a plate-like adapter, as well as the sub plate, is used to mount four differential transmitters or three differential pressure transmitters and a static pressure transmitter.
Abstract:
The present invention provides compositions and methods for modulating leukocyte activation. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating leukocyte activation are provided. Compositions and methods for the treatment of disorders related to leukocyte dysfunction or dysregulation are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating leukocyte activation.
Abstract:
The present invention provides compositions and methods for modulating lymphocyte activation. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating lymphocyte activation are provided. Compositions and methods for the treatment of disorders related to lymphocyte dysfunction or dysregulation are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating lymphocyte activation.
Abstract:
A mounting plate is disclosed that is adapted to be positioned between a main flow line and at least two differential pressure transmitters, to place the two differential pressure transmitters in fluid communication with a pair of pipeline taps on opposite sides of a flow reducing orifice plate in the main flow line is disclose. The mounting plate includes a plate-like body generally rectangular in cross section along its longitudinal axis and longer than it is wide along its transverse axis. The plate-like body includes a pair of ports that extend through the body and are in fluid communication with the pair of pressure taps with the longitudinal axis of the body parallel to the main flow line. A plurality of passageways or bores extend into the body to connect the ports to various combinations of pressure transmitters. One or more mounting holes for the transmitters are on a line that intersects the longitudinal axis of the body at an angle to allow some of the passageways or bores to be drilled straight and parallel to the longitudinal axis of the body between the mounting holes.
Abstract:
The present invention is directed to novel polypeptides, nucleic acids and related molecules which have an effect on or are related to the cell cycle. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are methods for identifying novel compositions which mediate cell cycle bioactivity, and the use of such compositions in diagnosis and treatment of disease.